EUVIMEDEUVIMED entdecken
Crossref

Five Years of Progress in CRISPR Clinical Trials (2019–2024)

Kevin Davies, Alex Philippidis, Rodolphe Barrangou iD

The CRISPR Journal · 2024

DOI: 10.1089/crispr.2024.0081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The CRISPR Journal, 2024. Verfasst von Kevin Davies und 2 weiteren Autor:innen. Beteiligte Einrichtung: The CRISPR Journal, Mary Ann Liebert Inc., New Rochelle, New York, USA. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Clinical Trials as Topic, Genetic Therapy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In July 2019, Victoria Gray became the first patient with sickle cell disease to receive a CRISPR-based cell therapy as a volunteer in the exa-cel clinical trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. Barely four years later, the ensuing therapy, branded as Casgevy, received approval from regulatory agencies in Europe, the United States, and the Middle East, ushering in a new era of CRISPR-based medicines. During this period, scores of other clinical trials have been launched, including many actively recruiting patients across phase 1, phase 2, and phase 3 clinical trials around the world. In this brief Perspective, we collate the latest information on therapeutic clinical trials featuring CRISPR, base and prime editing, across a range of both in vivo and ex vivo gene and cell therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingCRISPR-Cas SystemsClinical Trials as TopicGenetic TherapyHumansAnemia, Sickle CellClustered Regularly Interspaced Short Palindromic RepeatsCell- and Tissue-Based Therapy

Autor:innen und Institutionen

  • The CRISPR Journal, Mary Ann Liebert Inc., New Rochelle, New York, USA.
  • Genetic Engineering & Biotechnology News, Mary Ann Liebert Inc., New Rochelle, New York, USA.
  • North Carolina State University, Raleigh, North Carolina, USA.

ORCID-Profile: Rodolphe Barrangou

Zitieren

APA

Davies, K., Philippidis, A., & Barrangou, R. (2024). Five Years of Progress in CRISPR Clinical Trials (2019–2024). The CRISPR Journal. https://doi.org/10.1089/crispr.2024.0081

Vancouver

Davies K, Philippidis A, Barrangou R. Five Years of Progress in CRISPR Clinical Trials (2019–2024). The CRISPR Journal. 2024. doi:10.1089/crispr.2024.0081

BibTeX
@article{Davies2024,
  author = {Davies, Kevin and Philippidis, Alex and Barrangou, Rodolphe},
  title = {Five Years of Progress in CRISPR Clinical Trials (2019–2024)},
  journal = {The CRISPR Journal},
  year = {2024},
  doi = {10.1089/crispr.2024.0081}
}
Kostenlos starten →